Recent Updates
Recently added Catalysts
ECOR Positive Sentiment

electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2023 Financial Results on Wednesday, March 13, 2024

Tuesday, March 5, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: electroCore, Inc. announced that it will release its financial results for the fourth quarter and the year ending December 31, 2023, on March 13, 2024. The announcement follows the close of the market and will be followed by a conference call at 4:30 PM EST where management will discuss the results and field investor questions. The company's commitment to bioelectronic medicine and wellness reflects its dedication to healthcare innovation through non-invasive technologies.
Price reaction · baseline $6.75 (2024-03-04 close) · hit after-hours · clean, no other ECOR news in the window
day 0 close · peak
-1.8%

Market Sentiment Analysis

POSITIVE FACTORS

  • Scheduled announcement of Q4 and full-year financial results shows transparency.
  • Management will address questions during a conference call, enhancing investor communication.
  • Focus on bioelectronic medicine indicates innovation in healthcare technology.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~7 mo
High dilution risk
Lead asset
GammaCore
Phase 2 · Chronic Cluster Headache

Full Press Release Details

ROCKAWAY, N.J., March 05, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will report financial results for the fourth quarter and year ended December 31, 2023, after the close of the market on Wednesday, March 13, 2024. Management will host a conference call and webcast at 4:30 PM EST to discuss the financial results and answer questions.
Wednesday, March 13, 4:30 PM EST
Domestic: 877-407-8835
International: located here
Conference ID: 13744117
Webcast: electroCore Earnings Webcast
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. Our focus is the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance in the United States and select overseas markets.
For more information, visit www.electrocore.com.

Frequently Asked Questions

When will electroCore report its financial results?

electroCore will report its financial results on March 13, 2024.

What time is the conference call on financial results?

The conference call will take place at 4:30 PM EST.

How can I access the electroCore webcast?

You can access the electroCore webcast via their Earnings Webcast link.

What technology does electroCore focus on?

electroCore specializes in non-invasive vagus nerve stimulation (nVNS) technology.

Which markets does electroCore serve?

electroCore serves the U.S. and select overseas markets.

ShareAdd on Google
Tags: ECOR Viatris Investor Conferences Healthcare electroCore bioelectronic medicine financial results Q4 2023 wellness
Last updated: Mar 5, 2024

Biotech snapshot

Cash runway
$10M liquidity · $1M/mo burn
~7 mo
High dilution risk
Lead asset
GammaCorePhase 2
Chronic Cluster Headache →